Search
                    COVID19 Paid Clinical Trials in Connecticut
A listing of 12  COVID19  clinical trials  in Connecticut  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 12 of 12
        
        
    
                The state of Connecticut currently has 12 active clinical trials seeking participants for COVID19 research studies. These trials are conducted in various cities, including New Haven, Hartford, Farmington and Stamford. 
            
                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    Featured Trial
                
                Peripheral vascular disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Peripheral vascular disease
    
    
                            Conditions: 
                                    
        
            
                        Peripheral vascular disease
                    
                                    
                
                                    Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
                                
            
            
        Recruiting
                            
            
                Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology driven by ongoing viral replication. This trial will evaluate S-217622 (ensitrelvir), an anti-SARS-CoV2 3C-like protease inhibitor (PI) developed by Shionogi \&; Co. Ltd.
The study design is a randomized, placebo-controlled, multi-center international clinical trial that will evaluate the clinical efficacy of ensitrelvir when given in addit...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/18/2025
            
            Locations: Yale University (Site 025-001), New Haven, Connecticut         
        
        
            Conditions: COVID-19
        
            
        
    
                
                                    RECOVER-ENERGIZE Platform Protocol
                                
            
            
        Recruiting
                            
            
                This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes.
This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating interventions to address and improve exercise intolerance and post-exertional malaise (PEM) as ma...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/16/2025
            
            Locations: Yale - New Haven Hospital, New Haven, Connecticut         
        
        
            Conditions: Long COVID, Long Covid19, Long Covid-19
        
            
        
    
                
                                    A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.
This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/18/2025
            
            Locations: Clinical Research Consulting, Milford, Connecticut         
        
        
            Conditions: Influenza, COVID-19 (Coronavirus Disease 2019)
        
            
        
    
                
                                    A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
                                
            
            
        Recruiting
                            
            
                The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).
In order to represent a more recently circulating SARS-CoV-2 variant, the main study endpoints will now evaluate the VXA-CoV2-3.3 (KP.2 strain) vaccine, and not the VXA-CoV2-3.1 (XBB.1.5 strain)...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/03/2025
            
            Locations: Stamford Therapeutics Consortium, Stamford, Connecticut  +1 locations         
        
        
            Conditions: SARS-CoV2, COVID-19
        
            
        
    
                
                                    Brain-Training Treatment for Long COVID in Older Adults
                                
            
            
        Recruiting
                            
            
                This research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults. The investigators hypothesize that computerized brain-training will be an acceptable and feasible intervention for treating Long COVID symptoms in older adults. The investigators also expect to provide initial evidence that computerized brain-training has potential for improving thinking, mood, and other aspects of everyday function...  Read More             
        
        
    Gender:
                ALL
            Ages:
                60 years and above
            Trial Updated:
                03/25/2025
            
            Locations: UConn Health, Farmington, Connecticut         
        
        
            Conditions: Post-Acute COVID-19 Syndrome
        
            
        
    
                
                                    Music Mindfulness Study 2a.
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or co...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut  +1 locations         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    Drum Circle Synchrony Study 2c.a.
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or co...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut  +1 locations         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    Evaluating the Community Drum Circle
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased America due to disproportionate effects of social factors such as racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of Persons of African Descent(PAD) or other marginalized groups and are not designed to be culturally rel...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut  +1 locations         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    Evaluating Social Perception Dynamics
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or co...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut  +1 locations         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    Evaluating the Impact of Social Music
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or co...  Read More             
        
        
    Gender:
                ALL
            Ages:
                16 years and above
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut  +1 locations         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
                                
            
            
        Recruiting
                            
            
                The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy children. The trial is divided into 5 individual studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies will receive study vaccine as a shot depending on what group they are in.
* Substudy A design: Phase 1 includes participa...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 6 months and 11 years
            Trial Updated:
                05/13/2024
            
            Locations: Yale University School of Medicine, New Haven, Connecticut  +2 locations         
        
        
            Conditions: SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19
        
            
        
    
                
                                    I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
                                
            
            
        Recruiting
                            
            
                The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a big impact on reducing mortality and the need for, as well as duration, of mechanical ventilation.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                03/15/2024
            
            Locations: Yale Cancer Center, New Haven, Connecticut  +1 locations         
        
        
            Conditions: COVID-19
        
            
        
    1 - 12 of 12
            
            
        